Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 140,869 |
|
|||||
| News | - | ||||||
| Day High | 3.68 | Low High |
|||||
| Day Low | 3.42 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| ChromaDex Corporation | CDXC | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.14 | 3.95% | 3.68 | 17:06:45 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.53 | 3.42 | 3.68 | 3.66 | 3.54 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,845 | 140,869 | US$ 3.56 | US$ 501,543 | - | 1.25 - 4.65 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:40:14 | 5 | US$ 3.68 | USD |
ChromaDex Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 274.13M | 75.31M | - | 83.57M | -4.94M | -0.07 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ChromaDex News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDXC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.47 | 3.68 | 3.36 | 3.46 | 171,613 | 0.21 | 6.05% |
| 1 Month | 3.70 | 4.65 | 2.89 | 3.78 | 359,400 | -0.02 | -0.54% |
| 3 Months | 1.56 | 4.65 | 1.46 | 3.16 | 348,391 | 2.12 | 135.90% |
| 6 Months | 1.32 | 4.65 | 1.2801 | 2.84 | 200,114 | 2.36 | 178.79% |
| 1 Year | 1.32 | 4.65 | 1.25 | 2.44 | 140,618 | 2.36 | 178.79% |
| 3 Years | 8.95 | 10.78 | 1.15 | 4.06 | 304,873 | -5.27 | -58.88% |
| 5 Years | 4.45 | 23.66 | 1.15 | 8.38 | 488,481 | -0.77 | -17.30% |
ChromaDex Description
| ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors. |
